SYNACT — SynAct Pharma AB Share News
0.000.00%
- SEK821.62m
- SEK756.91m
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026
Sweden's SynAct Pharma Q4 net loss widens as expenses rise
Brief: SynAct Pharma Q4 Sales SEK 0
Brief: Synact Pharma Appoints Malin Wikstrand As Interim CFO
Brief: SynAct Pharma To Buy Back Own Shares
Brief: SynAct Pharma Board, Management Enter Lock-Up Agreements
Brief: Synact Pharma Management, Chairman Have Acquired Shares
Brief: SynAct Pharma Q3 Sales SEK 0
Brief: Synact Pharma Proposes EGM For Share Acquisition Authorization
Brief: Synact Pharma CFO Bjorn Westberg Leaves Company
Brief: SynAct Pharma Q2 Sales SEK 0
Brief: Synact Pharma Gets SEK 17.7 Mln After Second Warrant Conversion
Brief: SynAct To Get SEK 17.7 Mln After Conversion Of Warrants
Brief: Synact Pharma Board, Management Buy Shares Worth Over SEK 1 Mln
Brief: Synact Pharma Shares In Directed Issue At Subscription Price Of SEK 16 Per Share
Brief: SynAct Pharma Takes Out Credit Facility Of SEK 30 Million